These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18093273)

  • 1. The utility of 1- and 3-month protocol biopsies on renal allograft function: a randomized controlled study.
    Kurtkoti J; Sakhuja V; Sud K; Minz M; Nada R; Kohli HS; Gupta KL; Joshi K; Jha V
    Am J Transplant; 2008 Feb; 8(2):317-23. PubMed ID: 18093273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies.
    Töz H; Sen S; Seziş M; Duman S; Ozkahya M; Ozbek S; Hoşcoşkun C; Atabay G; Ok E
    Transplant Proc; 2004; 36(1):134-6. PubMed ID: 15013324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of 6-month protocol renal biopsy under modern immunosuppression.
    Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A
    Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the protocol biopsies in renal allograft recipients.
    Baczkowska T; Perkowska-Francka A; Durlik M; Cieciura T; Nowacka-Cieciura E; Pazik J; Lewandowska D; Mroz A; Matlosz B; Chmura A; Galazka Z; Lao M
    Transplant Proc; 2003 Sep; 35(6):2179-81. PubMed ID: 14529881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
    Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
    Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function outcomes in kidney transplant recipients after conversion to everolimus-based immunosuppression regimen with CNI reduction or elimination.
    Cataneo-Dávila A; Zúñiga-Varga J; Correa-Rotter R; Alberú J
    Transplant Proc; 2009 Dec; 41(10):4138-46. PubMed ID: 20005355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
    Aoun B; Decramer S; Vitkevic R; Wannous H; Bandin F; Azema C; Callard P; Brocheriou I; Ulinski T
    Pediatr Nephrol; 2013 Mar; 28(3):493-8. PubMed ID: 23111894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
    Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological findings in early routine biopsies of stable renal allograft recipients.
    Rush DN; Henry SF; Jeffery JR; Schroeder TJ; Gough J
    Transplantation; 1994 Jan; 57(2):208-11. PubMed ID: 8310509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
    Solez K; Vincenti F; Filo RS
    Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological features of renal allograft biopsies in ABO minor-mismatched kidney transplantation.
    Shimizu T; Tanabe K; Tokumoto T; Shimmura H; Ishikawa N; Ishida H; Toma H; Kawaguchi H; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2003; 17 Suppl 10():9-13. PubMed ID: 12823250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo sirolimus-based regimen in Thai renal transplant recipients.
    Townamchai N; Avihingsanon Y; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Transplant Proc; 2008 Sep; 40(7):2206-8. PubMed ID: 18790193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study.
    Pascual M; Vallhonrat H; Cosimi AB; Tolkoff-Rubin N; Colvin RB; Delmonico FL; Ko DS; Schoenfeld DA; Williams WW
    Transplantation; 1999 Mar; 67(5):737-41. PubMed ID: 10096531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure.
    Carmellini M; Collini A; Ruggieri G; Garosi G; Bernini M
    Transplant Proc; 2008; 40(6):1858-61. PubMed ID: 18675070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we have to treat subclinical rejections in early protocol renal allograft biopsies?
    Masin-Spasovska J; Spasovski G; Dzikova S; Petrusevska G; Lekovski Lj; Ivanovski N; Popov Z
    Transplant Proc; 2007 Oct; 39(8):2550-3. PubMed ID: 17954170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.